Plasma proteins break the habits a cell biology bench has. They are abundant enough to swamp a blot, they exist in several forms and complexes, serum in the culture medium already contains most of them, and several are measured clinically, so a research reagent and a diagnostic one are held to different standards. The questions are which form the clone sees and what the sample actually contains.
An albumin antibody and an apob antibody in an abundant matrix
Albumin is the most abundant protein in plasma and in most culture media, which makes it both a target and the commonest source of background: a secondary antibody raised in an animal exposed to bovine serum albumin will find the albumin in your blocking buffer. Apolipoprotein B is carried on lipoproteins rather than free, so what a blot reads depends on whether the particle was disrupted, and quantification against a purified standard is unreliable unless the standard is in the same particle state.
A fibrinogen antibody and an osteocalcin antibody on processed proteins
Fibrinogen is cleaved to fibrin and cross linked, so a clone may see the intact molecule, a chain, the fragment pattern of degradation, or the polymer, and the sample type decides which is there: citrated plasma, serum with the fibrinogen consumed, or a clot. Osteocalcin is carboxylated at three residues and the uncarboxylated form is a separate measurement with its own clinical meaning, so a kit that does not state which form it measures is not usable for that comparison.
An ngal antibody and an lcn2 antibody, one protein under two names
Neutrophil gelatinase-associated lipocalin and lipocalin 2 are the same protein, and catalogues list both names, sometimes at different prices. It circulates as a monomer, a homodimer and in complex with matrix metalloproteinase 9, and the forms have different sources, which is why kidney injury measurements specify the form and the matrix. Urine and plasma differ, storage matters, and a research kit with no form stated is measuring a mixture whose composition changes with the sample's own history.
A cd59 antibody and a c5b-9 antibody on complement
These two are complements of each other in the literal sense: the membrane attack complex is what the pathway builds, and the surface regulator is what stops it forming on host cells. An antibody against the complex has to be specific for the assembled neoepitope rather than for a free component, which is the whole difficulty, and staining is read as deposition on tissue rather than as abundance. The regulator is a small glycosylphosphatidylinositol-anchored protein, so the epitope survives some processing badly and flow cytometry is the cleaner read.
gad antibodies and what an autoantibody reagent means
Glutamic acid decarboxylase antibodies are usually discussed as the patient's own autoantibodies rather than as a reagent, which is a different product entirely: an assay to detect them in serum, calibrated in units against an international standard, and interpreted against a cut-off. A research antibody against the enzyme is the opposite, a reagent to detect the protein in a section or a blot. Catalogues carry both under similar names, and a sentence about the immunogen or the intended use settles which is in the tube.
Serum in the medium, and what it does to these measurements
Culture medium with serum already contains albumin, transferrin, apolipoproteins, complement components and growth factors, at concentrations that dwarf what the cells secrete. So any secretion measurement needs a serum-free window before collection, a serum-only control well, or a species-specific antibody that does not recognise the bovine protein. This is the single most common reason a secreted protein blot reads high in every lane, and it is fixed in the experimental design rather than in the antibody.
Research grade against diagnostic grade on the same analyte
Several proteins here are measured clinically, so a catalogue offers a research antibody, a matched pair for a research kit, and a diagnostic assay for the same analyte, and their prices differ severalfold. What the diagnostic version buys is traceable calibration, lot release against a specification, matrix validation and documentation. A research kit is adequate for comparing treated with untreated in one study; it is not adequate for comparing with a published clinical range, and that boundary is worth stating in the method.
Reading the immunogen before the application list
For this class the immunogen is the most informative line on the datasheet: a peptide from a processed region, a purified native protein, or a recombinant fragment each predict which forms will be seen. A clone raised against native purified protein often fails on a denatured blot and works in ELISA; a peptide clone frequently does the opposite. Where a vendor states only the application list, ask for the immunogen, since it explains the failures before they happen.
Questions people ask about apoe antibody
Why does a secreted protein blot read high in every lane?
Because serum in the medium already contains it. Use a serum-free collection window, a medium-only control, or a species-specific antibody.
Are NGAL and lipocalin 2 different products?
No, the same protein under two names. What differs between kits is which form, monomer, dimer or MMP-9 complex, they measure.
Can a research kit be compared with a clinical reference range?
No. Clinical ranges assume traceable calibration and matrix validation the research kit does not carry.